Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EBITDA (2016 - 2025)

Scienture Holdings' EBITDA history spans 13 years, with the latest figure at -$5.2 million for Q2 2025.

  • On a quarterly basis, EBITDA fell 244.85% to -$5.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was -$15.7 million, a 40.85% decrease, with the full-year FY2025 number at -$42.6 million, down 2012.6% from a year prior.
  • EBITDA hit -$5.2 million in Q2 2025 for Scienture Holdings, down from -$3.6 million in the prior quarter.
  • Over the last five years, EBITDA for SCNX hit a ceiling of -$218763.0 in Q3 2022 and a floor of -$5.5 million in Q1 2024.
  • Historically, EBITDA has averaged -$2.0 million across 5 years, with a median of -$1.2 million in 2021.
  • Biggest five-year swings in EBITDA: tumbled 988.85% in 2021 and later soared 83.12% in 2022.
  • Tracing SCNX's EBITDA over 5 years: stood at -$782324.0 in 2021, then crashed by 228.58% to -$2.6 million in 2022, then decreased by 29.38% to -$3.3 million in 2023, then surged by 55.03% to -$1.5 million in 2024, then plummeted by 244.85% to -$5.2 million in 2025.
  • Business Quant data shows EBITDA for SCNX at -$5.2 million in Q2 2025, -$3.6 million in Q1 2025, and -$1.5 million in Q2 2024.